Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 806.9 g/mol |
---|---|
Molecular Formula | C36H70O19 |
XLogP3 | -3 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 28 |
Exact Mass | 806.45113000 g/mol |
Monoisotopic Mass | 806.45113000 g/mol |
Topological Polar Surface Area | 263 Ų |
Heavy Atom Count | 55 |
Formal Charge | 0 |
Complexity | 986 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 9 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6538
Submission : 1986-08-14
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35157
Submission : 2020-11-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35157
Submission : 2020-11-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6538
Submission : 1986-08-14
Status : Active
Type : IV
About the Company : SIDLEYCHEM has focused on the application development and product promotion of construction chemicals such as mortars and coating additives for many years. To provide customers wit...
Global Sales Information
Company :
Hydroxypropyl Cellulose
Drug Cost (USD) : 239,782
Year : 2022
Prescribers : 103
Prescriptions : 241
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Hydroxypropyl Cellulose
Drug Cost (USD) : 1,792,903
Year : 2021
Prescribers : 574
Prescriptions : 1860
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Hydroxypropyl Cellulose
Drug Cost (USD) : 1,371,336
Year : 2020
Prescribers : 640
Prescriptions : 1629
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Hydroxypropyl Cellulose
Drug Cost (USD) : 2,929,218
Year : 2019
Prescribers : 1022
Prescriptions : 3686
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Hydroxypropyl Cellulose
Drug Cost (USD) : 3,158,196
Year : 2018
Prescribers : 1148
Prescriptions : 4188
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Hydroxypropyl Cellulose
Drug Cost (USD) : 2,990,871
Year : 2017
Prescribers : 1162
Prescriptions : 4305
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Hydroxypropyl Cellulose
Drug Cost (USD) : 2,138,123
Year : 2016
Prescribers : 1362
Prescriptions : 3514
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Hydroxypropyl Cellulose
Drug Cost (USD) : 0
Year : 2015
Prescribers : 1710
Prescriptions : 0
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
HYDROXYPROPYL CELLULOSE
Drug Cost (USD) : 2,830,802
Year : 2014
Prescribers : 1757
Prescriptions : 5526
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
ABOUT THIS PAGE
27
PharmaCompass offers a list of Hydroxypropyl Cellulose API API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydroxypropyl Cellulose API manufacturer or Hydroxypropyl Cellulose API supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxypropyl Cellulose API manufacturer or Hydroxypropyl Cellulose API supplier.
PharmaCompass also assists you with knowing the Hydroxypropyl Cellulose API API Price utilized in the formulation of products. Hydroxypropyl Cellulose API API Price is not always fixed or binding as the Hydroxypropyl Cellulose API Price is obtained through a variety of data sources. The Hydroxypropyl Cellulose API Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LACRISERT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LACRISERT, including repackagers and relabelers. The FDA regulates LACRISERT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LACRISERT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LACRISERT manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LACRISERT supplier is an individual or a company that provides LACRISERT active pharmaceutical ingredient (API) or LACRISERT finished formulations upon request. The LACRISERT suppliers may include LACRISERT API manufacturers, exporters, distributors and traders.
click here to find a list of LACRISERT suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A LACRISERT DMF (Drug Master File) is a document detailing the whole manufacturing process of LACRISERT active pharmaceutical ingredient (API) in detail. Different forms of LACRISERT DMFs exist exist since differing nations have different regulations, such as LACRISERT USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A LACRISERT DMF submitted to regulatory agencies in the US is known as a USDMF. LACRISERT USDMF includes data on LACRISERT's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The LACRISERT USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of LACRISERT suppliers with USDMF on PharmaCompass.
LACRISERT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LACRISERT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LACRISERT GMP manufacturer or LACRISERT GMP API supplier for your needs.
A LACRISERT CoA (Certificate of Analysis) is a formal document that attests to LACRISERT's compliance with LACRISERT specifications and serves as a tool for batch-level quality control.
LACRISERT CoA mostly includes findings from lab analyses of a specific batch. For each LACRISERT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LACRISERT may be tested according to a variety of international standards, such as European Pharmacopoeia (LACRISERT EP), LACRISERT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LACRISERT USP).